Not Yet RecruitingNot Applicable

PROmega Pilot Study of Clinic-based DHA Blood Screening in Early Pregnancy

United States650 participantsStarted 2026-05

Plain-language summary

This pilot study will explore feasibility of routine implementation of the recommended blood-based screening of DHA status in early pregnancy in routine clinical care.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients initiating prenatal care at participating clinics who are eligible for early pregnancy blood testing per American College of Obstetricians and Gynecologists (ACOG) standards Exclusion Criteria: * None

What they're measuring

Screening uptake percentage

Timeframe: First 20 weeks of pregnancy

Trial details

NCT IDNCT07271758

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08

Contact for this trial

Katherine Sauder, PhD

336-716-1280 katherine.sauder@advocatehealth.org

View on ClinicalTrials.gov More Nutrient Deficiency trials